Literature DB >> 25873584

Diversity of metabolic profiles of cystic fibrosis Pseudomonas aeruginosa during the early stages of lung infection.

Karin Meinike Jørgensen1, Tina Wassermann2, Helle Krogh Johansen3, Lasse Engbo Christiansen4, Søren Molin5, Niels Høiby6, Oana Ciofu1.   

Abstract

Pseudomonas aeruginosa is the dominant pathogen infecting the airways of cystic fibrosis (CF) patients. During the intermittent colonization phase, P. aeruginosa resembles environmental strains but later evolves to the chronic adapted phenotype characterized by resistance to antibiotics and mutations in the global regulator genes mucA, lasR and rpoN. Our aim was to understand the metabolic changes occurring over time and between niches of the CF airways. By applying Phenotype MicroArrays, we investigated changes in the carbon and nitrogen catabolism of subsequently clonally related mucoid and non-mucoid (NM) lung and sinus P. aeruginosa isolates from 10 CF patients (five intermittently colonized/five chronically infected). We found the most pronounced catabolic changes for the early/late NM isolate comparisons, with respiratory reduction seen for all chronically infecting isolates and two intermittently colonizing isolates. Fewer differences were observed between sinus and lung isolates, showing a higher degree of isolate similarity between these two niches. Modest respiratory changes were seen for the early isolate/PAO1 comparisons, indicating colonization with environmental isolates. Assignment of metabolic pathways via the KEGG database showed a prevalence of substrates involved in the metabolism of Ala, Asp and Glu, d-Ala, and Arg and Pro. In conclusion, extensive heterogeneity in the metabolic profiles of the P. aeruginosa isolates was observed from the initial stages of the infection, showing a rapid diversification of the bacteria in the heterogeneous environment of the lung. Metabolic reduction seems to be a common trait and therefore an adaptive phenotype, though it can be reached via multiple metabolic pathways.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25873584     DOI: 10.1099/mic.0.000093

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  12 in total

Review 1.  Biomarkers for cystic fibrosis drug development.

Authors:  Marianne S Muhlebach; J P Clancy; Sonya L Heltshe; Assem Ziady; Tom Kelley; Frank Accurso; Joseph Pilewski; Nicole Mayer-Hamblett; Elizabeth Joseloff; Scott D Sagel
Journal:  J Cyst Fibros       Date:  2016-10-27       Impact factor: 5.482

2.  Metabolic basis for the evolution of a common pathogenic Pseudomonas aeruginosa variant.

Authors:  Dallas L Mould; Mirjana Stevanovic; Alix Ashare; Daniel Schultz; Deborah A Hogan
Journal:  Elife       Date:  2022-05-03       Impact factor: 8.713

3.  Generalized Growth of Estuarine, Household and Clinical Isolates of Pseudomonas aeruginosa.

Authors:  Kelly E Diaz; Susanna K Remold; Ogochukwu Onyiri; Maura Bozeman; Peter A Raymond; Paul E Turner
Journal:  Front Microbiol       Date:  2018-02-27       Impact factor: 5.640

4.  Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients.

Authors:  Natália Candido Caçador; Carolina Paulino da Costa Capizzani; Lídia Alice Gomes Monteiro Marin Torres; Renata Galetti; Oana Ciofu; Ana Lúcia da Costa Darini; Niels Høiby
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

5.  A Milk Foodomics Investigation into the Effect of Pseudomonas fluorescens Growth under Cold Chain Conditions.

Authors:  Paolo Bellassi; Gabriele Rocchetti; Lorenzo Morelli; Biancamaria Senizza; Luigi Lucini; Fabrizio Cappa
Journal:  Foods       Date:  2021-05-24

6.  PAMDB: a comprehensive Pseudomonas aeruginosa metabolome database.

Authors:  Weiliang Huang; Luke K Brewer; Jace W Jones; Angela T Nguyen; Ana Marcu; David S Wishart; Amanda G Oglesby-Sherrouse; Maureen A Kane; Angela Wilks
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

7.  Convergent Metabolic Specialization through Distinct Evolutionary Paths in Pseudomonas aeruginosa.

Authors:  Ruggero La Rosa; Helle Krogh Johansen; Søren Molin
Journal:  mBio       Date:  2018-04-10       Impact factor: 7.867

8.  Intraspecies Signaling between Common Variants of Pseudomonas aeruginosa Increases Production of Quorum-Sensing-Controlled Virulence Factors.

Authors:  Dallas L Mould; Nico J Botelho; Deborah A Hogan
Journal:  mBio       Date:  2020-08-25       Impact factor: 7.867

9.  The Pseudomonas aeruginosa Complement of Lactate Dehydrogenases Enables Use of d- and l-Lactate and Metabolic Cross-Feeding.

Authors:  Yu-Cheng Lin; William Cole Cornell; Jeanyoung Jo; Alexa Price-Whelan; Lars E P Dietrich
Journal:  MBio       Date:  2018-09-11       Impact factor: 7.867

Review 10.  Adapting to the Airways: Metabolic Requirements of Pseudomonas aeruginosa during the Infection of Cystic Fibrosis Patients.

Authors:  Ruggero La Rosa; Helle Krogh Johansen; Søren Molin
Journal:  Metabolites       Date:  2019-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.